Thyroid hormone in cardiac surgery

Vascular Pharmacology

Volumn 52, Issue 3-4, 2010, Pages 131-137

  Ranasinghe, Aaron M ^a,b   Bonser, Robert S ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Department of Cardiothoracic Surgery Edgbaston   (United Kingdom)

Author keywords

Brain stem death; Cardiac surgery; Myocardial protection; Thyroid hormone; Triiodothyronine

Indexed keywords

LIOTHYRONINE; METHYLPREDNISOLONE; PLACEBO; THYROTROPIN; THYROXINE;

BRAIN DEATH; BRAIN STEM; CARDIOPULMONARY BYPASS; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; EUTHYROID SICK SYNDROME; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; HEART SURGERY; HEART TRANSPLANTATION; HEMODYNAMICS; HORMONAL THERAPY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; NONHUMAN; ORGAN DONOR; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURGICAL STRESS;

ADULT; ANIMALS; CARDIAC SURGICAL PROCEDURES; CHILD; CLINICAL TRIALS AS TOPIC; EUTHYROID SICK SYNDROMES; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TRIIODOTHYRONINE;

EID: 76849101581     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.11.004     Document Type: Review

References (82)

1. Auer J., Berent R., Weber T., Lassnig E., and Eber B. Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin. Cardiol. 26 (2003) 569-573
2. Bahouth S.W. Thyroid hormones transcriptionally regulate the beta 1-adrenergic receptor gene in cultured ventricular myocytes. J. Biol. Chem. 266 (1991) 15863-15869
3. Bennett-Guerrero E., Jimenez J.L., White W.D., D'Amico E.B., Baldwin B.I., and Schwinn D.A. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 Study Group. JAMA 275 (1996) 687-692
4. Bennett-Guerrero E., Kramer D.C., and Schwinn D.A. Effect of chronic and acute thyroid hormone reduction on perioperative outcome. [See Comments.]. [Review] [68 Refs]. Anesth. Analg. 85 (1997) 30-36
5. Bettendorf M., Schmidt K.G., Grulich-Henn J., Ulmer H.E., and Heinrich U.E. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 356 (2000) 529-534
6. Biondi B., Palmieri E.A., Lombardi G., and Fazio S. Subclinical hypothyroidism and cardiac function. Thyroid 12 (2002) 505-510
7. Bluhm W.F., Meyer M., Sayen M.R., Swanson E.A., and Dillmann W.H. Overexpression of sarcoplasmic reticulum Ca2+-ATPase improves cardiac contractile function in hypothyroid mice. Cardiovasc. Res. 43 (1999) 382-388
8. Bremner W.F., Taylor K.M., Baird S., Thomson J.E., Thomson J.A., Ratcliffe J.G., Lawrie T.D., and Bain W.H. Hypothalamo-pituitary-thyroid axis function during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 75 (1978) 392-399
9. Brent G.A., and Hershman J.M. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J. Clin. Endocrinol. Metab. 63 (1986) 1-8
10. Burman K.D. Is triiodothyronine administration beneficial in patients undergoing coronary artery bypass surgery?. JAMA 275 (1996) 723-724
11. Cerillo A.G., Sabatino L., Bevilacqua S., Farneti P.A., Scarlattini M., Forini F., and Glauber M. Nonthyroidal illness syndrome in off-pump coronary artery bypass grafting. Ann. Thorac. Surg. 75 (2003) 82-87
12. Chen Y.F., Kobayashi S., Chen J., Redetzke R.A., Said S., Liang Q., and Gerdes A.M. Short term triiodo-l-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats. J. Mol. Cell Cardiol. 44 (2008) 180-187
13. Chopra I.J. Euthyroid sick syndrome: is it a misnomer?. J. Clin. Endocrinol. Metab. 82 (1997) 329-334
14. Chopra I.J., Huang T.S., Beredo A., Solomon D.H., Chua Teco G.N., and Mead J.F. Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3, 5, 3′-triiodothyronine in sera of patients with nonthyroidal illnesses. J. Clin. Endocrinol. Metab. 60 (1985) 666-672
15. Chowdhury D., Ojamaa K., Parnell V.A., McMahon C., Sison C.P., and Klein I. A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. J. Thorac. Cardiovasc. Surg. 122 (2001) 1023-1025
16. Danzi S., and Klein I. Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid 12 (2002) 467-472
17. Davis P.J., and Davis F.B. Nongenomic actions of thyroid hormone on the heart. [Review] [62 Refs]. Thyroid 12 (2002) 459-466
18. De Groot L.J. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J. Clin. Endocrinol. Metab. 84 (1999) 151-164
19. Dillmann W.H. Cardiac function in thyroid disease: clinical features and management considerations. [Review] [69 Refs]. Ann. Thor. Surg. 56 Suppl-14 (1993)
20. Dimmick S., Badawi N., and Randell T. Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery. Cochrane. Database. Syst. Rev. (2004) CD004220
21. Drucker D.J., and Burrow G.N. Cardiovascular surgery in the hypothyroid patient. Arch. Intern. Med. 145 (1985) 1585-1587
22. Faber J., Petersen L., Wiinberg N., Schifter S., and Mehlsen J. Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid 12 (2002) 319-324
23. Fliers E., Alkemade A., and Wiersinga W.M. The hypothalamic-pituitary-thyroid axis in critical illness. Best. Pract. Res. Clin. Endocrinol. Metab. 15 (2001) 453-464
24. Forfar J.C., Muir A.L., Sawers S.A., and Toft A.D. Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. N. Engl. J. Med. 307 (1982) 1165-1170
25. Goarin J.P., Cohen S., Riou B., Jacquens Y., Guesde R., Le Bret F., Aurengo A., and Coriat P. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth. Analg. 83 (1996) 41-47
26. Haas N., Camphausen C., and Kececioglu D. Clinical review: thyroid hormone replacement in children after cardiac surgery - is it worth a try?. Crit. Care 10 (2006) 213
27. Hing A.J., Hicks M., Garlick S.R., Gao L., Kesteven S.H., Faddy S.C., Wilson M.K., Feneley M.P., and Macdonald P.S. The effects of hormone resuscitation on cardiac function and hemodynamics in a porcine brain-dead organ donor model. Am. J. Transplant. 7 (2007) 809-817
28. Hoit B.D., Khoury S.F., Shao Y., Gabel M., Liggett S.B., and Walsh R.A. Effects of thyroid hormone on cardiac {beta}-adrenergic responsiveness in conscious baboons. Circulation 96 (1997) 592-598
29. Holland F.W., Brown Jr. P.S., Weintraub B.D., and Clark R.E. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". Ann. Thor. Surg. 52 (1991) 46-50
30. Iglesias P., Munoz A., Prado F., Guerrero M.T., Macias M.C., Ridruejo E., Tajada P., and Diez J.J. Alterations in thyroid function tests in aged hospitalized patients: prevalence, aetiology and clinical outcome. Clin. Endocrinol. (Oxf.) 70 (2009) 961-967
31. Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid 7 (1997) 139-145
32. Jeevanandam V., Todd B., Regillo T., Hellman S., Eldridge C., and McClurken J. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J. Heart Lung Transplant. 13 (1994) 681-687
33. Jones T.H., Hunter S.M., Price A., and Angelini G.D. Should thyroid function be assessed before cardiopulmonary bypass operations?. Ann. Thorac. Surg. 58 (1994) 434-436
34. Khoury S.F., Hoit B.D., Dave V., Pawloski-Dahm C.M., Shao Y., Gabel M., Periasamy M., and Walsh R.A. Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca2+-cycling proteins in the baboon: implications for the force-frequency and relaxation-frequency relationships. Circ. Res. 79 (1996) 727-735
35. Kiss E., Brittsan A.G., Edes I., Grupp I.L., Grupp G., and Kranias E.G. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Circ. Res. 83 (1998) 608-613
36. Klein I. Thyroid hormone and the cardiovascular system. [Review] [64 Refs]. Am. J. Med. 88 (1990) 631-637
37. Klein I., and Danzi S. Thyroid disease and the heart. Circulation 116 (2007) 1725-1735
38. Klein I., and Danzi S. Thyroid hormone treatment to mend a broken heart. J. Clin. Endocrinol. Metab. 93 (2008) 1172-1174
39. Klein I., and Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344 (2001) 501-509
40. Klein I., and Ojamaa K. Thyroid hormone-targeting the heart. Endocrinology 142 (2001) 11-12
41. Klein I., and Ojamaa K. Thyroid hormone: targeting the vascular smooth muscle cell. Circ. Res. 88 (2001) 260-261
42. Klemperer J.D., Klein I., Gomez M., Helm R.E., Ojamaa K., Thomas S.J., Isom O.W., and Krieger K. Thyroid hormone treatment after coronary-artery bypass surgery. N. Engl. J. Med. 333 (1995) 1522-1527
43. Klemperer J.D., Zelano J., Helm R.E., Berman K., Ojamaa K., Klein I., Isom O.W., and Krieger K. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J. Thorac. Cardiovasc. Surg. 109 (1995) 457-465
44. Klemperer J.D., Klein I.L., Ojamaa K., Helm R.E., Gomez M., Isom O.W., and Krieger K.H. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann. Thorac. Surg. 61 (1996) 1323-1327
45. Mackie A.S., Booth K.L., Newburger J.W., Gauvreau K., Huang S.A., Laussen P.C., DiNardo J.A., del Nido P.J., Mayer J.E.J., Jonas R.A., McGrath E., Elder J., and Roth S.J. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J. Thorac. Cardiovasc. Surg. 130 (2005) 810-816
46. Mullis-Jansson S.L., Argenziano M., Corwin S., Homma S., Weinberg A.D., Williams M., Rose E.A., and Smith C.R. A randomised double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J. Thorac. Cardiovasc. Surg. 117 (1999) 1128-1135
47. Murzi B., Iervasi G., Masini S., Moschetti R., Vanini V., Zucchelli G., and Biagini A. Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass. Ann. Thorac. Surg. 59 (1995) 481-485
48. Novitzky D., Wicomb W.N., Cooper D.K., and Tjaalgard M.A. Improved cardiac function following hormonal therapy in brain dead pigs: relevance to organ donation. Cryobiology 24 (1987) 1-10
49. Novitzky D., Human P.A., and Cooper D.K. Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs. Ann. Thorac. Surg. 45 (1988) 50-55
50. Novitzky D., Cooper D.K., Barton C.I., Greer A., Chaffin J., Grim J., and Zuhdi N. Triiodothyronine as an inotropic agent after open heart surgery. J. Thorac. Cardiovasc. Surg. 98 (1989) 972-977
51. Novitzky D., Matthews N., Shawley D., Cooper D.K., and Zuhdi N. Triiodothyronine in the recovery of stunned myocardium in dogs. Ann. Thorac. Surg. 51 (1991) 10-16
52. Novitzky D., Cooper D.K., Rosendale J.D., and Kauffman H.M. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation 82 (2006) 1396-1401
53. O'Connor C.J., March R., and Tuman K.J. Severe myxedema after cardiopulmonary bypass. Anesth. Analg. 96 (2003) 62-64
54. Ojamaa K., Balkman C., and Klein I.L. Acute effects of triiodothyronine on arterial smooth muscle cells. Ann. Thorac. Surg. 56 (1993) S61-S66
55. Ojamaa K., Sabet A., Kenessey A., Shenoy R., and Klein I. Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific. Endocrinology 140 (1999) 3170-3176
56. Ojamaa K., Kenessey A., and Klein I. Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology 141 (2000) 2139-2144
57. Osman F., Gammage M.D., and Franklyn J.A. Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid 12 (2002) 483-487
58. Pantos C., Malliopoulou V., Paizis I., Moraitis P., Mourouzis I., Tzeis S., Karamanoli E., Cokkinos D.D., Carageorgiou H., Varonos D., and Cokkinos D.V. Thyroid hormone and cardioprotection: study of P38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart. Mol. Cell. Biochem. 242 (2003) 173-180
59. Pantos C., Mourouzis I., Saranteas T., Clave G., Ligeret H., Noack-Fraissignes P., Renard P.Y., Massonneau M., Perimenis P., Spanou D., Kostopanagiotou G., and Cokkinos D.V. Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion?. Basic Res. Cardiol. 104 (2009) 69-77
60. Park K.W., Dai H.B., Ojamaa K., Lowenstein E., Klein I., and Sellke F.W. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth. Analg. 85 (1997) 734-738
61. Parle J.V., Maisonneuve P., Sheppard M.C., Boyle P., and Franklyn J.A. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358 (2001) 861-865
62. Peeters R.P., Wouters P.J., Kaptein E., van Toor H., Visser T.J., and Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J. Clin. Endocrinol. Metab. 88 (2003) 3202-3211
63. Peeters R.P., van der G.S., Wouters P.J., Darras V.M., van Toor H., Kaptein E., Visser T.J., and Van den B.G. Tissue thyroid hormone levels in critical illness. J. Clin. Endocrinol. Metab. 90 (2005) 6498-6507
64. Peeters R.P., Wouters P.J., van Toor H., Kaptein E., Visser T.J., and Van den Berghe G. Serum 3, 3′, 5′-triiodothyronine (rt3) and 3, 5, 3′-triiodothyronine/rt3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J. Clin. Endocrinol. Metab. 90 (2005) 4559-4565
65. Powner D.J., Hendrich A., Lagler R.G., Ng R.H., and Madden R.L. Hormonal changes in brain dead patients. Crit. Care Med. 18 (1990) 702-708
66. Ranasinghe A.M., Quinn D.W., Pagano D., Edwards N., Faroqui M., Graham T.R., Keogh B.E., Mascaro J., Riddington D.W., Rooney S.J., Townend J.N., Wilson I.C., and Bonser R.S. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin i release after on-pump coronary artery bypass grafting. Circulation 114 (2006) I-245
67. Rohrer D., and Dillmann W.H. Thyroid hormone markedly increases the MRNA coding for sarcoplasmic reticulum Ca2+-ATPase in the rat heart. J. Biol. Chem. 263 (1988) 6941-6944
68. Rosendale J.D., Kauffman H.M., McBride M.A., Chabalewski F.L., Zaroff J.G., Garrity E.R., Delmonico F.L., and Rosengard B.R. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 75 (2003) 482-487
69. Rosendale J.D., Kauffman H.M., McBride M.A., Chabalewski F.L., Zaroff J.G., Garrity E.R., Delmonico F.L., and Rosengard B.R. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 75 (2003) 1336-1341
70. Saatvedt K., Lindberg H., Geiran O.R., Fiane A., Seem E., Michelsen S., Pedersen T., and Hagve T.A. Thyroid function during and after cardiopulmonary bypass in children. Acta Anaesthesiol. Scand. 42 (1998) 1100-1103
71. Schmidt B.M.W., Martin N., Georgens A.C., Tillmann H.C., Feuring M., Christ M., and Wehling M. Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers. J. Clin. Endocrinol. Metab. 87 (2002) 1681-1686
72. Simmerman H.K., and Jones L.R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 78 (1998) 921-947
73. Syed A.U., El Watidy A.F., Akhlaque N.B., Wahba A., El Oakley R.M., Imran K., Al Bukhari E.A., and Al Fagih M.R. Coronary bypass surgery in patients on thyroxin replacement therapy. Asian Cardiovasc. Thorac. Ann. 10 (2002) 107-110
74. Taniguchi S., Kitamura S., Kawachi K., Doi Y., and Aoyama N. Effects of hormonal supplements on the maintenance of cardiac function in potential donor patients after cerebral death. Eur. J. Cardiothorac. Surg. 6 (1992) 96-101
75. Utiger R.D. Altered thyroid function in nonthyroidal illness and surgery - to treat or not to treat?. N. Engl. J. Med. 333 (1995) 1562-1563
76. Van den B.G. The neuroendocrine response to stress is a dynamic process. Best. Pract. Res. Clin. Endocrinol. Metab. 15 (2001) 405-419
77. Velissaris T., Tang A.T.M., Wood P.J., Hett D.A., and Ohri S.K. Thyroid function during coronary surgery with and without cardiopulmonary bypass. Eur. J. Cardio-Thorac. Surg. 36 (2009) 148-154
78. Venkateswaran R.V., Steeds R.P., Quinn D.W., Nightingale P., Wilson I.C., Mascaro J.G., Thompson R.D., Townend J.N., and Bonser R.S. The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur. Heart J. (2009)
79. Votapka T.V., Canvasser D.A., Pennington D.G., Koga M., and Swartz M.T. Effect of triiodothyronine on graft function in a model of heart transplantation. Ann. Thorac. Surg. 62 (1996) 78-82
80. Wheeldon D.R., Potter C.D., Oduro A., Wallwork J., and Large S.R. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant. 14 (1995) 734-742
81. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81 (2001) 1097-1142
82. Yoneda K., Takasu N., Higa S., Oshiro C., Oshiro Y., Shimabukuro M., and Asahi T. Direct effects of thyroid hormones on rat coronary artery: nongenomic effects of triiodothyronine and thyroxine. Thyroid 8 (1998) 609-613